𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantitative Determination of Orlistat(Tetrahydrolipostatin, Ro 18-0647) in HumanPlasma by High-performance LiquidChromatography Coupled with Ion Spray Tandem Mass Spectrometry

✍ Scribed by Bennett, Patrick K.; Li, Yu-Tsyir; Edom, Richard; Henion, Jack


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
355 KB
Volume
32
Category
Article
ISSN
1076-5174

No coin nor oath required. For personal study only.

✦ Synopsis


A rapid, sensitive and speciÐc analytical method was developed and validated to quantify tetrahydrolipostatin (Orlistat, Ro 18-0647) in human plasma in order to provide pharmacokinetic data from clinical trials. This method employs a preliminary plasma protein precipitation step followed by a simple, one-step liquid-liquid extraction procedure to isolate Ro 18-0647 and its pentadeuterated internal standard, Ro from the biological 18-0647-d 5 , matrix. Reconstituted extracts were analyzed by liquid chromatography/ion spray tandem mass spectrometry (LC/MS/MS) in the selected reaction monitoring (SRM) mode. Chromatography was carried out using a 2 mm i.d. Γ‚ 50 mm Deltabond Phenyl column. The eluent was acetonitrile-2 mM ammonium acetate (90 : 10). The retention time of the analyte was 1.2 min and chromatographic run times were less than 1.5 min. No interferences from anticoagulants, collection devices or endogenous constituents of the plasma were observed. The assay has a lower limit of quantitation (LLQ) of 0.20 ng ml-1 plasma and a lower limit of detection (LLD) of 0.10 ng ml-1 plasma, based on 1 ml aliquots. The capability to detect 0.025 ng ml-1 in plasma has also been demonstrated. The calibration graphs were linear from 0.20 to 10 ng ml-1. The assay was initially validated with a linear range of 0.20-1.0 ng ml-1. This range was later extended and validated to an upper level of quantitation of 10 ng ml-1. Intra-and inter-assay precision studies showed a mean variability of less than 10% . The recovery, inter-assay precision and accuracy of the method were within acceptable bioanalytical standards. The assay has been shown to reliably provide automated, unattended sample analysis for ΒΏ150 samples per day. In an additional series of tests, Ro 18-0467 was shown to be stable under conditions that might be encountered during the analysis of samples from clinical trials. This LC/MS/MS assay procedure for Ro 18-0647 in human plasma has proven to be robust, sensitive, speciÐc, accurate and reproducible. This method has been used to analyze over 5000 study samples.


πŸ“œ SIMILAR VOLUMES


Low Picogram Determination of Ro 48-6791
✍ M. Zell; C. Husser; G. Hopfgartner πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 263 KB πŸ‘ 1 views

A coupled liquid chromatography/tandem mass spectrometry assay was developed for simultaneous determination of Ro 48-6791 and its secondary amine metabolite in human plasma samples with a quantification limit for both compounds of 1 pg/mL using a 1 mL plasma aliquot. The method exploits the enhanced

Quantitative Analysis of Mevinolinic Aci
✍ R. E. Calaf; M. Carrascal; E. GelpΓ­; J. Abian πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 2 views

Mevinolinic acid (MVA), the major active metabolite of Lovastatin in human blood, is analysed by microbore high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Quantification is carried out by using methylmevinolinic acid (MMVA) as internal standard. Positive-and

Quantitative determination of Ecteinasci
✍ Rosing, H.; Hillebrand, M. J. X.; Jimeno, J. M.; GΓ³mez, A.; Floriano, P.; Faircl πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

A method was developed for the bio-analysis of Ecteinascidin 743 (ET-743) using miniaturized liquid chromatography (LC) coupled to an electrospray ionization sample inlet (TurbolonSpray) and two quadrupole mass analyzers (LC/ESI-MS/MS). Solid-phase extraction was used as a sample pretreatment proced